The clinical manifestations and prognosis of cutaneous leishmaniasis (CL) can be
influenced by the immune response of the patient and the species of the parasite. A
case of atypical clinical presentation of CL, with development of non-characteristic
lesions, poor response to therapy, and a long time to resolution is reported.
Confirmatory laboratory tests included parasite detection, indirect
immunofluorescence, Montenegro skin test, polymerase chain reaction, and parasite
identification by multilocus enzyme electrophoresis. The parasite was identified as
Leishmaniabraziliensis. The lesion was unresponsive to three
complete courses of N-methylglucamine antimoniate intramuscular, and to treatment
with pentamidine. The patient did not tolerate amphotericin B. The lesion finally
receded after treatment with intravenous N-methylglucamine antimoniate. It is
essential to ensure the accuracy of diagnosis and the appropriate treatment, which
can include the use a second choice drug or a different route of administration.